Any feedback?
Literature summary extracted from
- The histidine 115-histidine 134 dyad mediates the lactonase activity of mammalian serum paraoxonases (2006), J. Biol. Chem., 281, 7649-7656.
Cloned(Commentary)
| EC Number | Cloned (Comment) | Organism |
|---|---|---|
| 3.1.1.25 | wild-type-like rePON1-G2E6 and its various mutants are expressed as fusion proteins with thioredoxin and His6 tags | Homo sapiens |
| 3.1.1.25 | wild-type-like rePON1-G2E6 and its various mutants are expressed as fusion proteins with thioredoxin and His6 tags | Oryctolagus cuniculus |
Protein Variants
| EC Number | Protein Variants | Comment | Organism |
|---|---|---|---|
| 3.1.1.2 | H115A | activity with phenyl acetate is 0.3% compared to wild-type activity, activity with 2-naphthyl acetate is 0.3% of wild-type activity | Homo sapiens |
| 3.1.1.2 | H115Q | activity with phenyl acetate is 0.6% compared to wild-type activity, activity with 2-naphthyl acetate is 1% of wild-type activity | Homo sapiens |
| 3.1.1.2 | H115W | activity with phenyl acetate is 0.06% compared to wild-type activity, activity with 2-naphthyl acetate is 0.3% of wild-type activity | Homo sapiens |
| 3.1.1.2 | H134Q | activity with phenyl acetate is 9.9% compared to wild-type activity, activity with 2-naphthyl acetate is 3.1% of wild-type activity | Homo sapiens |
| 3.1.1.2 | H184Q | activity with phenyl acetate is 32% compared to wild-type activity, activity with 2-naphthyl acetate is 66% of wild-type activity | Homo sapiens |
| 3.1.1.2 | H184T | activity with phenyl acetate is 27% compared to wild-type activity, activity with 2-naphthyl acetate is 35% of wild-type activity | Homo sapiens |
| 3.1.1.2 | H285Q | activity with phenyl acetate is 12% compared to wild-type activity, activity with 2-naphthyl acetate is 19% of wild-type activity | Homo sapiens |
| 3.1.1.2 | H285S | activity with phenyl acetate is 10% compared to wild-type activity, activity with 2-naphthyl acetate is 61% of wild-type activity | Homo sapiens |
| 3.1.1.25 | H115A | activity with 5-(thioethyl)butyrolactone is 1.1% of wild-type activity, activity with 5-(thiobutyl)butyrolactone is 4.2% of wild-type activity, activity with delta-valerolactone, gamma-nonalactone or gamma-undecanoic lactone is less than 1% of wild-type activity | Oryctolagus cuniculus |
| 3.1.1.25 | H115A | activity with dicoumarin is 366% compared to wild-type activity, activity with delta-valerolactone is 3% of wild-type activity, activity with gamma-nonalactone is 1% of wild-type activity | Homo sapiens |
| 3.1.1.25 | H115Q | activity with dicoumarin is 268% compared to wild-type activity, activity with delta-valerolactone is 4.96% of wild-type activity, activity with gamma-nonalactone is 1.2% of wild-type activity. kcat/Km for delta-valerolactone is 2.2% of wild-type value, kcat/Km for gamma-nonalactone is 0.3% of wild-type value, kcat/Km for gamma-caprolactone is 1.4% of wild-type value, kcat/Km for 5-(thiobutyl)butyrolactone is 1.1% of wild-type value. Mutant with reduced lactonase activity, exhibits reduced or no biological function in ex vivo assay | Homo sapiens |
| 3.1.1.25 | H115Q/H134Q | activity with 5-(thioethyl)butyrolactone is 0.2% compared to wild-type activity, activity with 5-(thiobutyl)butyrolactone is 0.6% of wild-type activity, activity with delta-valerolactone, gamma-nonalactone or gamma-undecanoic lactone is less than 1% of wild-type activity | Oryctolagus cuniculus |
| 3.1.1.25 | H115Q/H134Q | kcat/Km for 5-(thiobutyl)butyrolactone is 0.2% of wild-type value mutant with reduced lactonase activity, exhibits reduced or no biological function in ex vivo assay | Homo sapiens |
| 3.1.1.25 | H115W | activity with dicoumarin is 261% compared to wild-type activity, activity with delta-valerolactone is 0.6% of wild-type activity, activity with gamma-nonalactone is 0.1% of wild-type activity | Homo sapiens |
| 3.1.1.25 | H134Q | activity with dicoumarin is 77% compared to wild-type activity, activity with delta-valerolactone is 13% of wild-type activity, activity with gamma-nonalactone is 22% of wild-type activity. kcat/Km for delta-valerolactone is 11% of wild-type value, kcat/Km for gamma-nonalactone is 8% of wild-type value, kcat/Km for gamma-caprolactone is 19% of wild-type value, kcat/Km for 5-(thiobutyl)butyrolactone is 6.5% of wild-type value. Mutant with reduced lactonase activity, exhibits reduced or no biological function in ex vivo assay | Homo sapiens |
| 3.1.1.25 | H184Q | activity with dicoumarin is 57% compared to wild-type activity, activity with delta-valerolactone is 44% of wild-type activity, activity with gamma-nonalactone is 44% of wild-type activity | Homo sapiens |
| 3.1.1.25 | H184T | activity with dicoumarin is 17% compared to wild-type activity, activity with delta-valerolactone is 35% of wild-type activity, activity with gamma-nonalactone is 39% of wild-type activity | Homo sapiens |
| 3.1.1.25 | H285Q | activity with dicoumarin is 22% compared to wild-type activity, activity with delta-valerolactone is 20% of wild-type activity, activity with gamma-nonalactone is 38% of wild-type activity | Homo sapiens |
| 3.1.1.25 | H285S | activity with dicoumarin is 13% compared to wild-type activity, activity with delta-valerolactone is 8% of wild-type activity, activity with gamma-nonalactone is 16% of wild-type activity | Homo sapiens |
| 3.1.8.1 | H115A | activity with paraoxon is 167% of wild-type activity, activity with 7-diethylphosphoro-3-cyanocoumarin is 119% of wild-type activity | Homo sapiens |
| 3.1.8.1 | H115Q | activity with paraoxon is 32% of wild-type activity, activity with 7-diethylphosphoro-3-cyanocoumarin is 25% of wild-type activity | Homo sapiens |
| 3.1.8.1 | H115W | activity with paraoxon is 195% of wild-type activity, activity with 7-diethylphosphoro-3-cyanocoumarin is 234% of wild-type activity | Homo sapiens |
| 3.1.8.1 | H134Q | activity with paraoxon is 602% of wild-type activity, activity with 7-diethylphosphoro-3-cyanocoumarin is 38% of wild-type activity | Homo sapiens |
| 3.1.8.1 | H184Q | activity with paraoxon is 8.9% of wild-type activity, activity with 7-diethylphosphoro-3-cyanocoumarin is 7.9% of wild-type activity | Homo sapiens |
| 3.1.8.1 | H184T | activity with paraoxon is 9.3% of wild-type activity, activity with 7-diethylphosphoro-3-cyanocoumarin is 2.7% of wild-type activity | Homo sapiens |
| 3.1.8.1 | H285Q | activity with paraoxon is 13% of wild-type activity, activity with 7-diethylphosphoro-3-cyanocoumarin is 4.3% of wild-type activity | Homo sapiens |
| 3.1.8.1 | H285S | activity with paraoxon is 53% of wild-type activity, activity with 7-diethylphosphoro-3-cyanocoumarin is 25% of wild-type activity | Homo sapiens |
KM Value [mM]
| EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
|---|---|---|---|---|---|---|
| 3.1.1.2 | 1.3 | - |
phenyl acetate | pH 8.0, wild-type enzyme | Homo sapiens |  |
| 3.1.1.2 | 3.6 | - |
phenyl acetate | pH 8.0, mutant enzyme H134Q | Homo sapiens | |
| 3.1.1.2 | 8.1 | - |
phenyl acetate | pH 8.0, mutant enzyme H115Q | Homo sapiens | |
| 3.1.1.2 | 9.7 | - |
phenyl acetate | pH 8.0, mutant enzyme H115Q/H134Q | Homo sapiens | |
| 3.1.1.25 | 0.27 | - |
5-(thiobutyl)butyrolactone | pH 8.0, wild-type enzyme | Homo sapiens | |
| 3.1.1.25 | 0.39 | - |
gamma-nonalactone | pH 8.0, wild-type enzyme | Homo sapiens | |
| 3.1.1.25 | 0.57 | - |
delta-valerolactone | pH 8.0, wild-type enzyme | Homo sapiens | |
| 3.1.1.25 | 0.68 | - |
5-(thiobutyl)butyrolactone | pH 8.0, mutant enzyme H134Q | Homo sapiens | |
| 3.1.1.25 | 0.89 | - |
gamma-nonalactone | pH 8.0, mutant enzyme H134Q | Homo sapiens | |
| 3.1.1.25 | 0.95 | - |
delta-valerolactone | pH 8.0, mutant enzyme H134Q | Homo sapiens | |
| 3.1.1.25 | 1 | - |
Gamma-caprolactone | pH 8.0, wild-type enzyme | Homo sapiens | |
| 3.1.1.25 | 1.54 | - |
gamma-nonalactone | pH 8.0, mutant enzyme H115Q | Homo sapiens | |
| 3.1.1.25 | 1.6 | - |
5-(thiobutyl)butyrolactone | pH 8.0, mutant enzyme H115Q | Homo sapiens | |
| 3.1.1.25 | 1.83 | - |
5-(thiobutyl)butyrolactone | pH 8.0, mutant enzyme H115Q/H134Q | Homo sapiens | |
| 3.1.1.25 | 2.97 | - |
Gamma-caprolactone | pH 8.0, mutant enzyme H134Q | Homo sapiens | |
| 3.1.1.25 | 3.8 | - |
Gamma-caprolactone | pH 8.0, mutant enzyme H115Q | Homo sapiens | |
| 3.1.1.25 | 8.5 | - |
delta-valerolactone | pH 8.0, mutant enzyme H115Q | Homo sapiens | |
| 3.1.8.1 | 0.75 | - |
paraoxon | pH 8.0, mutant enzyme H134Q | Homo sapiens | |
| 3.1.8.1 | 0.86 | - |
paraoxon | pH 8.0, wild-type enzyme | Homo sapiens | |
| 3.1.8.1 | 1.18 | - |
paraoxon | pH 8.0, mutant enzyme H115Q/H134Q | Homo sapiens | |
| 3.1.8.1 | 1.35 | - |
paraoxon | pH 8.0, mutant enzyme H115Q | Homo sapiens | |
Localization
| EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
|---|---|---|---|---|---|
| 3.1.1.2 | additional information | high density lipoprotein-associated enzyme | Homo sapiens | - |
- |
| 3.1.1.25 | additional information | high density lipoprotein-associated enzyme | Homo sapiens | - |
- |
| 3.1.1.25 | additional information | high density lipoprotein-associated enzyme | Oryctolagus cuniculus | - |
- |
| 3.1.8.1 | additional information | high density lipoprotein-associated enzyme | Homo sapiens | - |
- |
Metals/Ions
| EC Number | Metals/Ions | Comment | Organism | Structure |
|---|---|---|---|---|
| 3.1.1.2 | Ca2+ | Asp269 and Glu53 participate in the ligation of catalytic Ca2+ | Homo sapiens | |
| 3.1.1.25 | Ca2+ | Asp269 and Glu53 participate in the ligation of catalytic Ca2+ | Homo sapiens | |
| 3.1.1.25 | Ca2+ | Asp269 and Glu53 participate in the ligation of catalytic Ca2+ | Oryctolagus cuniculus | |
| 3.1.8.1 | Ca2+ | Asp269 and Glu53 participate in the ligation of catalytic Ca2+ | Homo sapiens | |
Organism
| EC Number | Organism | UniProt | Comment | Textmining |
|---|---|---|---|---|
| 3.1.1.2 | Homo sapiens | P27169 | - |
- |
| 3.1.1.25 | Homo sapiens | P27169 | - |
- |
| 3.1.1.25 | Oryctolagus cuniculus | Q9BGN0 | - |
- |
| 3.1.8.1 | Homo sapiens | P27169 | - |
- |
Purification (Commentary)
| EC Number | Purification (Comment) | Organism |
|---|---|---|
| 3.1.1.25 | wild-type-like rePON1-G2E6 and its various mutants are expressed as fusion proteins with thioredoxin and His6 tags | Homo sapiens |
| 3.1.1.25 | wild-type-like rePON1-G2E6 and its various mutants are expressed as fusion proteins with thioredoxin and His6 tags | Oryctolagus cuniculus |
Substrates and Products (Substrate)
| EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|---|
| 3.1.1.2 | 2-naphthyl acetate + H2O | - |
Homo sapiens | 2-naphthol + acetate | - |
? | |
| 3.1.1.2 | naphthalen-2-yl acetate + H2O | - |
Homo sapiens | 2-naphthol + acetate | - |
? | |
| 3.1.1.2 | phenyl acetate + H2O | - |
Homo sapiens | phenol + acetate | - |
? | |
| 3.1.1.25 | 5-(thiobutyl)butyrolactone + H2O | the lactonase and the esterase activity of PON1 is mediated by the His115-His134 | Homo sapiens | ? | - |
? | |
| 3.1.1.25 | 5-(thiobutyl)butyrolactone + H2O | the lactonase and the esterase activity of PON1 is mediated by the His115-His134 dyad | Oryctolagus cuniculus | ? | - |
? | |
| 3.1.1.25 | 5-(thioethyl)butyrolactone + H2O | the lactonase and the esterase activity of PON1 is mediated by the His115-His134 dyad | Oryctolagus cuniculus | ? | - |
? | |
| 3.1.1.25 | delta-valerolactone + H2O | - |
Homo sapiens | 5-hydroxypentanoic acid | - |
? | |
| 3.1.1.25 | delta-valerolactone + H2O | - |
Oryctolagus cuniculus | 5-hydroxypentanoic acid | - |
? | |
| 3.1.1.25 | dihydrocoumarin + H2O | - |
Homo sapiens | 3-(2-hydroxyphenyl)propanoic acid | - |
? | |
| 3.1.1.25 | gamma-caprolactone + H2O | - |
Homo sapiens | 4-hydroxyhexanoic acid | - |
? | |
| 3.1.1.25 | gamma-nonalactone + H2O | - |
Homo sapiens | 4-hydroxynonanoic acid | - |
? | |
| 3.1.1.25 | gamma-nonalactone + H2O | - |
Oryctolagus cuniculus | 4-hydroxynonanoic acid | - |
? | |
| 3.1.1.25 | gamma-undecanoic lactone + H2O | - |
Oryctolagus cuniculus | 4-hydroxyundecanoic acid | - |
? | |
| 3.1.8.1 | 5-(thiobutyryl)butyrolactone + H2O | - |
Homo sapiens | ? | - |
? | |
| 3.1.8.1 | 7-diethylphosphoro-3-cyanocoumarin + H2O | - |
Homo sapiens | 3-cyanocoumarin + diethyl phosphate | - |
? | |
| 3.1.8.1 | paraoxon + H2O | - |
Homo sapiens | 4-nitrophenol + diethyl phosphate | - |
? | |
Synonyms
| EC Number | Synonyms | Comment | Organism |
|---|---|---|---|
| 3.1.8.1 | PON1 | - |
Homo sapiens |
Turnover Number [1/s]
| EC Number | Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
|---|---|---|---|---|---|---|
| 3.1.1.2 | 7.4 | - |
phenyl acetate | pH 8.0, mutant enzyme H115Q/H134Q | Homo sapiens | |
| 3.1.1.2 | 10.5 | - |
phenyl acetate | pH 8.0, mutant enzyme H115Q | Homo sapiens | |
| 3.1.1.2 | 18 | - |
naphthalen-2-yl acetate | pH 8.0, wild-type enzyme | Homo sapiens | |
| 3.1.1.2 | 185 | - |
phenyl acetate | pH 8.0, mutant enzyme H134Q | Homo sapiens | |
| 3.1.1.2 | 854 | - |
phenyl acetate | pH 8.0, wild-type enzyme | Homo sapiens | |
| 3.1.1.25 | 0.38 | - |
gamma-nonalactone | pH 8.0, mutant enzyme H115Q | Homo sapiens | |
| 3.1.1.25 | 1.74 | - |
5-(thiobutyl)butyrolactone | pH 8.0, mutant enzyme H115Q/H134Q | Homo sapiens | |
| 3.1.1.25 | 2.27 | - |
Gamma-caprolactone | pH 8.0, mutant enzyme H115Q | Homo sapiens | |
| 3.1.1.25 | 5.57 | - |
gamma-nonalactone | pH 8.0, mutant enzyme H134Q | Homo sapiens | |
| 3.1.1.25 | 7.5 | - |
5-(thiobutyl)butyrolactone | pH 8.0, mutant enzyme H115Q | Homo sapiens | |
| 3.1.1.25 | 19.4 | - |
5-(thiobutyl)butyrolactone | pH 8.0, mutant enzyme H134Q | Homo sapiens | |
| 3.1.1.25 | 25 | - |
Gamma-caprolactone | pH 8.0, mutant enzyme H134Q | Homo sapiens | |
| 3.1.1.25 | 31 | - |
gamma-nonalactone | pH 8.0, wild-type enzyme | Homo sapiens | |
| 3.1.1.25 | 40 | - |
delta-valerolactone | pH 8.0, mutant enzyme H134Q | Homo sapiens | |
| 3.1.1.25 | 44 | - |
Gamma-caprolactone | pH 8.0, wild-type enzyme | Homo sapiens | |
| 3.1.1.25 | 69.4 | - |
delta-valerolactone | pH 8.0, mutant enzyme H115Q | Homo sapiens | |
| 3.1.1.25 | 116 | - |
5-(thiobutyl)butyrolactone | pH 8.0, wild-type enzyme | Homo sapiens | |
| 3.1.1.25 | 210 | - |
delta-valerolactone | pH 8.0, wild-type enzyme | Homo sapiens | |
| 3.1.8.1 | additional information | - |
additional information | - |
Homo sapiens | |
| 3.1.8.1 | 1 | - |
paraoxon | pH 8.0, mutant enzyme H115Q | Homo sapiens | |
| 3.1.8.1 | 1.09 | - |
paraoxon | pH 8.0, recombinant wild-type PON1 genetic variant G2E6 | Homo sapiens | |
| 3.1.8.1 | 4.2 | - |
paraoxon | pH 8.0, wild-type enzyme | Homo sapiens | |
| 3.1.8.1 | 4.7 | - |
paraoxon | pH 8.0, mutant enzyme H115Q/H134Q | Homo sapiens | |
| 3.1.8.1 | 12.7 | - |
paraoxon | pH 8.0, mutant enzyme H134Q | Homo sapiens | |
| 3.1.8.1 | 166 | - |
5-(thiobutyryl)butyrolactone | pH 8.0, recombinant wild-type PON1 genetic variant G2E6 | Homo sapiens | |
pH Optimum
| EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
|---|---|---|---|---|
| 3.1.1.2 | additional information | - |
pH-rate profile of PON1 with 2-naphthyl acetate | Homo sapiens |
| 3.1.8.1 | additional information | - |
pH-rate profile of PON1 with paraoxon | Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
